Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results.
about
Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System BlockadeInflammation in diabetic kidney diseaseGenetic polymorphisms of cytokine genes in type 2 diabetes mellitus.Diabetic nephropathy - complications and treatment.Effect of pentoxifylline on renal function and urinary albumin excretion in patients with diabetic kidney disease: the PREDIAN trial.Effects and clinical significance of pentoxifylline on the oxidative stress of rats with diabetic nephropathy.Diabetic nephropathy: What does the future hold?Novel drugs and intervention strategies for the treatment of chronic kidney disease.Emerging drugs for managing kidney disease in patients with diabetes.Chronic kidney disease: a new look at pathogenetic mechanisms and treatment options.Renoprotection and the Bardoxolone Methyl Story - Is This the Right Way Forward? A Novel View of Renoprotection in CKD Trials: A New Classification Scheme for Renoprotective Agents.Therapeutic approaches to diabetic nephropathy--beyond the RAS.Novel effective drugs for diabetic kidney disease? or not?Association of IL-6, TNF-α and IL-10 gene polymorphisms with type 2 diabetes mellitus.Ameliorative effects of pentoxifylline on NOS induced by diabetes in rat kidney.
P2860
Q26799443-C62A083A-4FF7-4118-8B30-6071C956AB86Q34023543-DE8A4390-3236-479B-92E3-5EB2A2943608Q34023565-D45BF08F-93DB-4230-9573-4FC476C6DEC4Q34387952-66413D26-F760-4125-8ADD-8B24155F632DQ34787799-601EA72F-2047-4A1E-87C3-5E0DFD476A45Q35662913-08FD7167-F1CC-4A55-BB27-2BAE248F61E7Q36441616-0AAC827C-F26A-4197-9E3F-87EEED24CD1EQ37219043-D1CD37C5-2750-49A4-81F0-168883C684C6Q38075029-591CEEA9-78B0-43EE-B7CC-2A1BF45D582CQ38087529-B1605DA7-5A28-4639-9AD0-B67277DA0E6EQ38107939-7F165FD9-EEA0-41AA-A2FB-D2E4B97F7B02Q38209811-F5E32BEE-9A2E-4192-9AA7-2B8AC12095CEQ38265818-F87653D3-EFDF-48CE-9068-EA631582D3B1Q44965438-ABC82915-F8AB-4B45-A31E-19158AF42CBEQ52883695-8AF3F527-7DA4-49F4-A2ED-AFC8D5006572
P2860
Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Pentoxifylline for renoprotect ...... . Rationale and basal results.
@en
Pentoxifylline for renoprotect ...... . Rationale and basal results.
@nl
type
label
Pentoxifylline for renoprotect ...... . Rationale and basal results.
@en
Pentoxifylline for renoprotect ...... . Rationale and basal results.
@nl
prefLabel
Pentoxifylline for renoprotect ...... . Rationale and basal results.
@en
Pentoxifylline for renoprotect ...... . Rationale and basal results.
@nl
P2093
P1476
Pentoxifylline for renoprotect ...... y. Rationale and basal results
@en
P2093
Beatriz Meneses
Haridian Herrera
Javier García
Mercedes Muros
P304
P356
10.1016/J.JDIACOMP.2010.09.003
P577
2010-12-08T00:00:00Z